Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS SE & CO. KGAA

(FRE)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 10/26 03:59:23 pm
39.795 EUR   -3.88%
12:05pEuropean ADRs Move Higher in Tuesday Trading
MT
06:15aFRESENIUS SE : Deutsche Bank sticks Neutral
MD
10/21FRESENIUS SE : Barclays reaffirms its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Fresenius : Bank of America – Global Healthcare Conference (PDF, 5.96 MB)

09/17/2021 | 10:32am EDT

Bank of America - Global Healthcare Conference 2021

September 15, 2021

Safe Harbor Statement

This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing.

Fresenius does not undertake any responsibility to update the forward-looking statements contained in this presentation.

Bank of America - Global Healthcare Conference 2021, September 15, 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

2

Agenda

01

Company Highlights

02

03

04

Strategic update

Financial review

Attachments

Q2/21 &

Outlook FY/21

Bank of America - Global Healthcare Conference 2021, September 15, 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

3

A Global Leader in Health Care Products and Services

in sales (FY/2020)

€ 36.3 bn

Global presence in 100+

countries

Leading market

#1 positions

Long-term opportunities in growing, non-cyclicalmarkets

100 +

Employees

worldwide

(as of June 30, 2021)

310,000+

Strong financial performance and cash flow generation

Bank of America - Global Healthcare Conference 2021, September 15, 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

4

Investment Highlights

Diversified healthcare Group

Leading positions in

Resilient business model

with four strong business

growing non-cyclical

based on megatrends

segments

markets

healthcare and demographics

Purpose-driven business

Strong financial

Reliable

delivers sustainable

performance and cash

dividend growth

contribution to society

flow generation

Bank of America - Global Healthcare Conference 2021, September 15, 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

5

Disclaimer

Fresenius SE & Co. KGaA published this content on 15 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 September 2021 14:31:06 UTC.


ę Publicnow 2021
All news about FRESENIUS SE & CO. KGAA
12:05pEuropean ADRs Move Higher in Tuesday Trading
MT
06:15aFRESENIUS SE : Deutsche Bank sticks Neutral
MD
10/21FRESENIUS SE : Barclays reaffirms its Buy rating
MD
10/18European ADRs Move Lower in Monday Trading
MT
10/14FRESENIUS : Kabi enters collaboration to enhance the supply of essential medicines for U.S..
PU
10/07FRESENIUS SE : NorldLB gives a Buy rating
MD
10/05FRESENIUS SE : Barclays maintains a Buy rating
MD
10/04FRESENIUS : Medical Care donates 250,000 euros to UNICEF – battle against COVID-19 p..
PU
09/30FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the German Securiti..
DJ
09/30FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 41 of the WpHG [the Ge..
DJ
More news
Analyst Recommendations on FRESENIUS SE & CO. KGAA
More recommendations
Financials
Sales 2021 37 432 M 43 428 M 43 428 M
Net income 2021 1 821 M 2 113 M 2 113 M
Net Debt 2021 22 786 M 26 435 M 26 435 M
P/E ratio 2021 12,2x
Yield 2021 2,16%
Capitalization 22 160 M 25 693 M 25 709 M
EV / Sales 2021 1,20x
EV / Sales 2022 1,07x
Nbr of Employees 312 734
Free-Float 73,1%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | FRE | DE0005785604 | MarketScreener
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 39,71 €
Average target price 49,34 €
Spread / Average Target 24,2%
EPS Revisions
Managers and Directors
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Wolfgang Kirsch Chairman-Supervisory Board
Sebastian Biedenkopf Legal, Compliance & Human Resources Director
Klaus-Peter MŘller Independent Member-Supervisory Board